ClinicalTrials.Veeva

Menu

East-West Hepatocellular Carcinoma Study Group

U

University of Milan

Status

Completed

Conditions

Carcinoma, Hepatocellular

Study type

Observational

Funder types

Other

Identifiers

NCT01237132
HCC EWE

Details and patient eligibility

About

The current treatment guidelines of hepatocellular carcinoma (HCC) of the American and European Associations for the Study of Liver Disease are based on the Barcelona-Clinic-Liver-Cancer classification (BCLC), which does not recommend surgery in patients with large, multinodular and macrovascular invasive disease. The aim of this study was to investigate the role of hepatic resection in a large retrospective multicentric cohort of patients resected for HCC regardless of the BCLC indications.

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • clinical diagnosis of hepatocellular carcinoma
  • candidate to liver resection as a curative treatment

Exclusion criteria

  • uncertain diagnosis of hepatocellular carcinoma
  • uncertain follow-up data

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems